What is

AELMHU?


REPORTS

ㅤㅤAccessReportsㅤ ㅤ

Check here for our latest update

Clinical Trial Reports

Check here for our latest update


NEWS

NEWS

AELMHU 15th anniversary web news
January 14, 2026

AELMHU celebrates 15 years of commitment to people with rare diseases

The Spanish Association of Orphan and Ultra-Orphan Drug Laboratories (AELMHU) is celebrating its 15th anniversary, a milestone that reaffirms the commitment of pharmaceutical companies dedicated to researching and developing treatments for people with diseases … Read more

INTERVIEWS


ASSOCIATED COMPANIES

RESEARCH AND COMMITMENT to rare diseases


AELMHU is a member of:


What is an orphan drug?

Orphan drugs (ODs) are innovative treatments, many of them biotechnological in origin, intended to diagnose, prevent, or treat patients with rare diseases for which there is no alternative therapy.